Kukje Pharma Co., Ltd.
002720 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002720001
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 야탑로 96-8, 성남시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-09-04 00:00 |
Regulatory Filings
생산중단
|
Korean | 9.3 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-08-13 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.6 KB | ||
| 2025-05-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.7 KB | ||
| 2025-05-20 00:00 |
Related Party Transaction
[기재정정]타인에대한채무보증결정
|
Korean | 18.6 KB | ||
| 2025-05-15 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 23.4 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 503.8 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 20.1 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 983.8 KB | ||
| 2025-03-06 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 983.2 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.7 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.0 KB |
Automate Your Workflow. Get a real-time feed of all Kukje Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Kukje Pharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kukje Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
South Korea
263050
Develops and commercializes a nasal spray for diabetic gastroparesis symptom relief.
United States of America
EVOK
United States of America
EVOK
Develops neurotoxins and dermal fillers for the medical aesthetics market.
United States of America
EOLS
United States of America
EOLS
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway
EXTX
Norway
EXTX
An oncology-focused biotech that discovers and develops medicines for hard-to-treat cancers.
United States of America
EXEL
United States of America
EXEL
Clinical-stage biotech developing vaccines and immunotherapies via a proprietary protein platform.
Sweden
EXPRS2
Sweden
EXPRS2
Develops innovative, sustained-delivery therapeutics for retinal diseases.
United States of America
EYPT
United States of America
EYPT
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
Spain
FAE
Spain
FAE
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium
FAGR
Belgium
FAGR
A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.
Ukraine
FARM
Ukraine
FARM